We first analyzed the correlation between the mRNA levels of METTL3 and PGC‐1α in 105 patients with primary AML and found a positive correlation between their expression levels (r = 0.3303, p = 0.0006) (Figure 4D). This evidence concerns the gene METTL3 and acute myeloid leukemia.